A new drug which could stop people getting Covid has reportedly been shown to protect 80 per cent of care home residents from infection during trials.
In the study of care home staff and residents scientists infused them with artificial antibodies in a bid to provide a temporary boost to immunity to coronavirus, The Times reports.
The pharmaceutical company behind the trials of the drug, Eli Lilly, were reported to have said the drug could be used quickly for people who were not yet vaccinated.
Janelle Sabo, at the company told the newspaper: “Because neutralising antibodies are immediate, they don’t require that your immune system mounts a response. "In fact it allows your immune system to slowly mount a response and kind of augment it.